Companies /Financial Services

Bain Capital Specialty Finance Inc

NYSE: BCSF Asset Management
$10.61
▼ $0.07 (−0.66%) today
Markets open · 3:08pm ET

BCSF at a Glance

Valuation
Market cap
$692.8M
P/E ratio
10.8
Dividend yield
15.80%
Profitability
Revenue (TTM)
$264.0M
Profit margin
24.2%
EPS (TTM)
$0.99
Price
52-week range
$11 – $13
Street target
$12.62
Earnings
Next report
Nov 9, 2026

Headquartered in Boston, MA Fiscal year ends December NYSE: BCSF baincapitalspecialtyfinance.com

About Bain Capital Specialty Finance

Bain Capital Specialty Finance, Inc. (NYSE: BCSF) is an externally managed specialty finance company structured as a business development company (BDC) under the Investment Company Act of 1940. The company focuses on lending to middle market companies through direct originations of secured debt, including first lien, first lien/last out, unitranche, and second lien debt, as well as investments in strategic joint ventures, equity investments, and corporate bonds. BCSF is managed by BCSF Advisors, LP, an SEC-registered investment adviser and subsidiary of Bain Capital Credit, LP. Since commencing investment operations in October 2016 through June 30, 2026, BCSF has invested approximately $10.1 billion in aggregate principal amount of debt and equity investments. As of June 30, 2026, the portfolio comprised investments in 214 companies across 30 industries, with 94.5% of debt investments in floating rate securities. The company operates through two strategic joint ventures — ISLP and SLP — which together held portfolios valued at approximately $2.3 billion. BCSF's investment objective is to generate current income and, to a lesser extent, capital appreciation for shareholders. Updated

BCSF Coverage

Frequently Asked Questions

What does Bain Capital Specialty Finance do?

Bain Capital Specialty Finance, Inc. (NYSE: BCSF) is an externally managed specialty finance company structured as a business development company (BDC) under the Investment Company Act of 1940.

What is the BCSF stock price target?

The Wall Street consensus 12-month price target for BCSF is $12.62.